MarketBeat
08 Aug 2026, 10:04 UTC · 6w ago
Verdict
Headline takes no side. We score GMED +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 84% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Globus Medical raised its full-year adjusted earnings forecast and reported a record non-GAAP diluted EPS of $1.34, a 56% increase year-over-year.
So whatAn upward revision in earnings guidance combined with record EPS typically triggers strong positive investor sentiment and price appreciation.
More positive than 99% of claims this week
Adjusted EBITDA margins expanded significantly to 35.4% from 28.0% year-over-year, with the company targeting mid-70% gross margins by 2027.
So whatStrong margin expansion and clear long-term profitability targets indicate improving operational efficiency and pricing power.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 92% of claims this week
Trauma revenue grew 31% year-over-year and international spine revenue rose 12% on a constant-currency basis.
More positive than 85% of claims this week
Enabling Technologies revenue fell 26% year-over-year due to a strategic shift from cash sales to flexible leasing and rental models.
More negative than 79% of claims this week
Nevro revenue declined 14.3% year-over-year, with a full recovery in trial volumes not expected until late in the fourth quarter.
More negative than 72% of claims this week
Which stocks this story touches
More positive than 84% of ticker scores this week
Reported strong revenue growth, record non-GAAP EPS, expanding margins, and raised its full-year earnings forecast.
More positive than 96% of relationship scores this week
[a_to_b] Globus Medical acquired Nevro in 2025 and is integrating its pain-management business.
More positive than 96% of relationship scores this week
[b_to_a] Nevro is a business unit within Globus Medical following its acquisition.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−8.9%
Price is moving against the score
$75.05 vs $82.35 close before publication (Aug 7) · not market-adjusted
GMED chart →